Clinical Trial Update: Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer. [Phase 3]

View source ↗

Summary

A Phase III clinical trial evaluating INR101 injection for PET/CT imaging in prostate cancer is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• INR101 Injection (INR101)

Snippet

Sponsor: Yunhe Pharmaceutical (Tianjin) Co., Ltd | Conditions: Prostate Cancer | Phase 3 | Status: NOT_YET_RECRUITING